TA
Last reporting period 31 Mar, 2024
Updated —
Last price
—
Market cap $B
1.615
Exchange
XNYS - New York Stock Exchange, Inc
2.2 B
Last period Assets ,USD
1%
Assets has increased in 5 years
What is Assets ?
Assets are the book value of the company's tangible and intangible property, as well as cash and debt rights.
See also Taro Pharmaceutical
Company Analysis
TARO valuation, rating, competitors, insights and company profile
Eyestock Rating
TARO financial analysis by Eyestock methodology
Valuation
TARO valuation using historical relative method
Statements
TARO Income Statements, Balance Sheet and Cash Flow Statements
Dividends
TARO dividend yield and annual dividend
Assets are the book value of the company's tangible and intangible property, as well as cash and debt rights.
Taro Pharmaceutical`s Assets for the period ended 2024-03-31 are 2.2 B USD
